
(R)-Tegoprazan
CAS No. 942195-56-4
(R)-Tegoprazan( (R)-CJ-12420; (R)-RQ-00000004 )
Catalog No. M29649 CAS No. 942195-56-4
(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
25MG | 826 | In Stock |
![]() ![]() |
100MG | 1768 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name(R)-Tegoprazan
-
NoteResearch use only, not for human use.
-
Brief Description(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase.
-
Description(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research.
-
In Vitro——
-
In Vivo——
-
Synonyms(R)-CJ-12420; (R)-RQ-00000004
-
PathwayMembrane Transporter/Ion Channel
-
TargetProton Pump
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number942195-56-4
-
Formula Weight387.38
-
Molecular FormulaC20H19F2N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL (129.07 mM; Need ultrasonic)
-
SMILESCN(C)C(C1=CC(O[C@H]2C3=C(F)C=C(F)C=C3OCC2)=C4C(N=C(N4)C)=C1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Takeshi Hanazawa, et al. Chromane Substituted Benzimidazole Derivatives. US20070142448A1.
molnova catalog



related products
-
Ilaprazole sodium hy...
Ilaprazole (IY-81149) sodium hydrate is an orally active proton pump inhibitor that irreversibly inhibits H+/K+-ATPase in rabbit parietal cells with a dose-dependent IC50 of 6 μM.
-
Ilaprazole
A potent, orally active proton pump inhibitor that irreversibly inhibits H+/K(+)-ATPase with IC50 of 6 uM.
-
Esomeprazole sodium
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells.